Cargando…

The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells

One of the major limits of chemotherapy is depending on the ability of the cancer cells to elude and adapt to different drugs. Recently, we demonstrated how the activation of the M2 muscarinic receptor could impair neuroblastoma cell proliferation. In the present paper, we investigate the possible e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucianò, Anna Maria, Perciballi, Elisa, Fiore, Mario, Del Bufalo, Donatella, Tata, Ada Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697391/ https://www.ncbi.nlm.nih.gov/pubmed/33182656 http://dx.doi.org/10.3390/ijms21228433

Ejemplares similares

The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells
por: Guerriero, Claudia, et al.
Publicado: (2021)

Cross Interaction between M2 Muscarinic Receptor and Notch1/EGFR Pathway in Human Glioblastoma Cancer Stem Cells: Effects on Cell Cycle Progression and Survival
por: Cristofaro, Ilaria, et al.
Publicado: (2020)

M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells
por: Pacini, Luca, et al.
Publicado: (2014)

M2 Muscarinic Receptor Activation Impairs Mitotic Progression and Bipolar Mitotic Spindle Formation in Human Glioblastoma Cell Lines
por: Di Bari, Maria, et al.
Publicado: (2021)

Functional Characterization of Muscarinic Receptors in Human Schwann Cells
por: Piovesana, Roberta, et al.
Publicado: (2020)

Distinct Agonist Regulation of Muscarinic Acetylcholine M(2)-M(3) Heteromers and Their Corresponding Homomers
por: Aslanoglou, Despoina, et al.
Publicado: (2015)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Notch Signal Mediates the Cross-Interaction between M2 Muscarinic Acetylcholine Receptor and Neuregulin/ErbB Pathway: Effects on Schwann Cell Proliferation
por: Piovesana, Roberta, et al.
Publicado: (2022)

Multitargeting nature of muscarinic orthosteric agonists and antagonists
por: Myslivecek, Jaromir
Publicado: (2022)

Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation
por: Di Bari, Maria, et al.
Publicado: (2018)

LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells
por: Maresca, Giovanna, et al.
Publicado: (2012)

The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M(2) receptor subtype
por: Español, Alejandro J., et al.
Publicado: (2020)

Control of Brain State Transitions with a Photoswitchable Muscarinic Agonist
por: Barbero‐Castillo, Almudena, et al.
Publicado: (2021)

DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo
por: Thompson, Karen J., et al.
Publicado: (2018)

FRET-Based Detection of M(1) Muscarinic Acetylcholine Receptor Activation by Orthosteric and Allosteric Agonists
por: Markovic, Danijela, et al.
Publicado: (2012)

[(11)C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors
por: Buiter, Hans JC, et al.
Publicado: (2013)

Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
por: Zlatopolskiy, Boris D., et al.
Publicado: (2020)

Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy
por: Jakubík, J, et al.
Publicado: (2011)

The beneficial effects of a muscarinic agonist on pancreatic β-cells
por: Ito, Yuzuru, et al.
Publicado: (2019)

Voltage Affects the Dissociation Rate Constant of the m2 Muscarinic Receptor
por: Ben Chaim, Yair, et al.
Publicado: (2013)

M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition
por: Cristofaro, Ilaria, et al.
Publicado: (2020)

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease()
por: Dale, Philippa R, et al.
Publicado: (2014)

The muscarinic agonist arecoline suppresses motor circuit hyperactivity in C. elegans
por: McCulloch, Katherine A, et al.
Publicado: (2020)

Bitopic Binding Mode of an M(1) Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes
por: Bradley, Sophie J., et al.
Publicado: (2018)

Agonist-induced changes in the modulation of K+ permeability and beating rate by muscarinic agonists in cultured heart cells
Publicado: (1982)

Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy
por: Sales, María E., et al.
Publicado: (2019)

Differential role of beta-arrestin ubiquitination in agonist-promoted down-regulation of M(1 )vs M(2 )muscarinic acetylcholine receptors
por: Mosser, Valerie A, et al.
Publicado: (2008)

Expression of M3 muscarinic acetylcholine receptors in gastric cancer
por: Mehedinţeanu, Alina Maria, et al.
Publicado: (2021)

Muscarinic receptor oligomerization
por: Marsango, Sara, et al.
Publicado: (2018)

Synchronization of pancreatic islets by periodic or non-periodic muscarinic agonist pulse trains
por: Adablah, Joel E., et al.
Publicado: (2019)

Effects of (a Combination of) the Beta(2)-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction
por: Maarsingh, Harm, et al.
Publicado: (2021)

Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists
por: Coppes, R P, et al.
Publicado: (2001)

Olfactory Neuroblastoma: The Adjunctive Role of Somatostatin Agonists After Surgery
por: Toral, Fernando Pazos, et al.
Publicado: (2021)

Molecular Conversion of Muscarinic Acetylcholine Receptor M(5) to Muscarinic Toxin 7 (MT7)-Binding Protein
por: Rondinelli, Sergio, et al.
Publicado: (2011)

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Functional Characterization of Cholinergic Receptors in Melanoma Cells
por: Lucianò, Anna Maria, et al.
Publicado: (2020)

Bcl-xL: A Focus on Melanoma Pathobiology
por: Lucianò, Anna Maria, et al.
Publicado: (2021)

Neuroprotective and Antioxidant Role of Oxotremorine-M, a Non-selective Muscarinic Acetylcholine Receptors Agonist, in a Cellular Model of Alzheimer Disease
por: Nuzzo, Domenico, et al.
Publicado: (2022)

Dualsteric modulators of the M2 muscarinic acetylcholine receptor
por: Bermudez, Marcel, et al.
Publicado: (2014)

Structure and Dynamics of the M(3) Muscarinic Acetylcholine Receptor
por: Kruse, Andrew C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tl74bfc3i8230o14bc4l4fgs0d